Agios Pharma (AGIO) Misses Q2 EPS by 4c

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.69), $0.04 worse than the analyst estimate of ($1.65). Revenue for the quarter came in at $44.74 million versus the consensus estimate of $26.57 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Boeing lands two U.S. defense contracts worth over $711M
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August